Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Genetics · Glutaric Acidemia Type 1

Why is 3 to 36 Months the Danger Window for GA1?

At a Glance

In Glutaric Acidemia Type 1 (GA1), the 3- to 36-month window is critical because rapid brain growth makes the striatum highly vulnerable to toxic acid buildup. During illnesses, this can cause a metabolic stroke, making strict emergency protocols essential to prevent irreversible brain damage.

In this answer

4 sections

01

Why the Striatum is Uniquely Vulnerable

02

Warning Signs of a Crisis

03

What Happens After 36 Months?

04

Protecting the Brain During the Danger Window

Between 3 and 36 months of age, a child’s brain goes through a period of massive, rapid growth and maturation [1][2]. During this specific window, children with Glutaric Acidemia Type 1 (GA1) are at the highest risk for sudden brain damage because a deep part of the brain called the striatum is uniquely vulnerable to the toxic acids that build up in the body [3][4].

When a child with GA1 gets sick, fasts, or runs a fever, their body breaks down proteins for energy, releasing large amounts of glutaric acid (GA) and 3-hydroxyglutaric acid (3-OHGA) [5][6]. During the 3- to 36-month developmental window, the striatum is working so hard to form new connections that it cannot handle the combined stress of the illness and the toxic acids. This can lead to rapid, irreversible damage often called a “metabolic stroke” [3][7].

While learning about this is daunting, there is a very reassuring reality: early diagnosis through Newborn Screening (NBS) combined with strict adherence to illness protocols is highly effective at preventing metabolic strokes [8][9].

Why the Striatum is Uniquely Vulnerable

The striatum is a cluster of neurons deep inside the brain that helps coordinate and smooth out muscle movements [10]. In GA1, several biological factors create a “perfect storm” that puts the striatum in danger during the toddler years:

  • Metabolic Entrapment: The toxic acids (GA and 3-OHGA) can easily cross from the bloodstream into the brain [11]. However, specific pump-like structures at the blood-brain barrier struggle to pump these acids back out [12]. As a result, the toxins get “trapped” inside the brain tissue and accumulate to dangerous levels [12][13].
  • Energy Failure: Brain development requires a massive amount of cellular energy. The toxic acids trapped in the brain interfere with the mitochondria (the power plants of the cells), severely reducing the energy available to the striatum [14][15]. When an everyday illness increases the brain’s energy needs, the striatum simply runs out of power, causing cells to become damaged [14][6].
  • Receptor Changes (Excitotoxicity): During the first three years of life, the brain dynamically changes the types of chemical receptors it uses to communicate [16][17]. The trapped GA1 toxins overstimulate specific receptors in the striatum, causing damage by over-exciting the nerve cells [18][19]. The medical team’s emergency protocol is designed specifically to prevent this chain reaction from happening.

Warning Signs of a Crisis

During an illness, it is vital to watch for physical signs that a metabolic crisis might be affecting the brain. Symptoms of acute striatal injury can include [3][2]:

  • Sudden floppiness or loss of head control
  • Loss of previously mastered motor skills (like sitting up or crawling)
  • Abnormal, repetitive, or stiff muscle movements
  • Extreme irritability followed by extreme sleepiness or lethargy

What Happens After 36 Months?

Parents often feel a sense of relief once their child passes their third birthday. After 36 months of age, the risk of a metabolic stroke decreases significantly [1][20].

As the brain’s rapid growth phase slows down, its energy demands stabilize [1][2]. The striatum’s pathways mature, making its cells far more resilient to the inflammation caused by glutaric acid [1][20]. However, keeping up with dietary control remains important even after the danger window to prevent long-term, slow-onset neurological complications later in life [21][11].

Protecting the Brain During the Danger Window

Because the striatum is so fragile during this 3- to 36-month window, strict management is critical:

  • Immediate Illness Management: The moment your child shows signs of illness (fever, vomiting, diarrhea), you must intervene to stop their body from breaking down its own proteins [5].
  • Follow the Emergency Protocol: This usually involves temporarily pausing natural protein intake, providing high-carbohydrate drinks, and seeking hospital care if they cannot keep fluids down [8][9]. Important: Protein intake is only paused temporarily (typically 24–48 hours maximum) under strict medical guidance. Pausing it for too long forces the body to break down its own muscle, which releases massive amounts of toxic acids.
  • Bring Your ER Letter: General emergency room staff often do not know about GA1. Always carry your “Metabolic Emergency Letter” and hand it directly to the triage nurse immediately upon arrival to ensure prompt treatment [8].
  • Maintain the Daily Diet: Sticking strictly to a low-lysine and low-tryptophan diet keeps the baseline level of toxic acids as low as possible [22]. Taking prescribed L-carnitine supplements daily is also critical, as it acts as a binder that helps the body safely flush out the toxic acids in urine [23].

Common questions in this guide

Why are babies and toddlers with GA1 at such high risk for brain damage?
Between 3 and 36 months of age, a child's brain undergoes rapid growth, requiring massive amounts of energy. Toxic acids from GA1 get trapped in the brain, interfering with energy production and making a deep brain structure called the striatum highly vulnerable to damage during illnesses.
What is a metabolic stroke in Glutaric Acidemia Type 1?
A metabolic stroke occurs when the brain is overwhelmed by toxic acids during an illness, fever, or fasting. This causes rapid, irreversible damage to the brain's striatum, leading to a sudden loss of motor skills and muscle control.
What are the warning signs of a brain injury crisis in GA1?
Warning signs include a sudden loss of head control, losing previously mastered motor skills like sitting up, abnormal stiff muscle movements, and extreme irritability followed by deep sleepiness. If these occur, immediate medical intervention is required.
How can parents protect a child's brain during a GA1 illness?
Parents must immediately intervene at the first sign of illness by following their medical emergency protocol. This typically involves temporarily pausing natural protein, providing high-carbohydrate drinks, and taking the child to the emergency room with their metabolic emergency letter.
What happens after a child with GA1 turns three years old?
After 36 months of age, the rapid growth phase of the brain slows down and its energy demands stabilize. The brain pathways mature, significantly decreasing the risk of a metabolic stroke, though dietary control remains important to prevent long-term complications.

Questions for Your Doctor

4 questions

  • •What specific neurological signs should prompt us to move from home management to heading immediately to the emergency room?
  • •Can you provide us with a signed, up-to-date Metabolic Emergency Letter to keep on hand for the ER staff?
  • •If my child is hospitalized during a severe illness, exactly how long is it safe to pause natural protein before we need to reintroduce it?
  • •What is our specific high-carbohydrate sick-day formula protocol, and at what exact temperature or fever threshold should we start using it?

Questions for You

3 questions

  • •Are our emergency sick-day supplies (high-carbohydrate formulas, medications, ER letter) fully stocked, easily accessible, and not expired?
  • •Do all of my child's caregivers, including grandparents and daycare staff, understand the absolute urgency of the sick day protocol?
  • •What early signs of a minor illness does my child usually show first, so we can start the sick day protocol as early as possible?

Related questions

Can You Have GA-1 With a Normal Newborn Screen?How Do You Manage Feeding in GA-1 With Severe Dystonia?What Are the Kidney Risks in Glutaric Acidemia Type 1?What Does Dietary Relaxation Mean for GA-1 After Age 6?What Is the Role of Riboflavin in GA-1 Treatment?What Triggers the GA1 Emergency Sick-Day Protocol?Why Do GA-1 Patients Need High-Dextrose IV Fluids?Why Is GA-1 Misdiagnosed as Abusive Head Trauma?Why Does the GA-1 Diet Restrict Lysine Over Tryptophan?

References

References (23)
  1. 1

    Phenotypic and Genotypic Characteristics of Adult-Onset Glutaric Aciduria Type 1: Report of Two Cases and a Literature Review.

    Wei L, Li J, Xie Z, et al.

    Brain and behavior 2025; (15(2)):e70281 doi:10.1002/brb3.70281.

    PMID: 39963939
  2. 2

    Clinico-Radiological Correlation in 26 Egyptian Children with Glutaric Acidemia Type 1.

    Sadek AA, Aladawy MA, Magdy RM, et al.

    Neuropediatrics 2021; (52(6)):431-440 doi:10.1055/s-0040-1722681.

    PMID: 33622013
  3. 3

    Patterns, evolution, and severity of striatal injury in insidious- vs acute-onset glutaric aciduria type 1.

    Boy N, Garbade SF, Heringer J, et al.

    Journal of inherited metabolic disease 2019; (42(1)):117-127 doi:10.1002/jimd.12033.

    PMID: 30740735
  4. 4

    Glutaric AciduriaType 1: Clinical and Molecular Study in Iranian Patients, 3 Novel Mutations.

    Pirzadeh Z, Houshmand M, Nasiri J, et al.

    Iranian journal of child neurology 2017; (11(4)):58-65.

    PMID: 29201125
  5. 5

    Oxidative Stress, Disrupted Energy Metabolism, and Altered Signaling Pathways in Glutaryl-CoA Dehydrogenase Knockout Mice: Potential Implications of Quinolinic Acid Toxicity in the Neuropathology of Glutaric Acidemia Type I.

    Seminotti B, Amaral AU, Ribeiro RT, et al.

    Molecular neurobiology 2016; (53(9)):6459-6475 doi:10.1007/s12035-015-9548-9.

    PMID: 26607633
  6. 6

    Protective effects of L-carnitine on behavioral alterations and neuroinflammation in striatum of glutaryl-COA dehydrogenase deficient mice.

    Guerreiro G, Faverzani J, Moura AP, et al.

    Archives of biochemistry and biophysics 2021; (709()):108970 doi:10.1016/j.abb.2021.108970.

    PMID: 34181873
  7. 7

    A review of patients with glutaric aciduria type 1 at Inkosi Albert Luthuli Central Hospital, Durban, South Africa.

    Govender R, Mitha A, Mubaiwa L

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2017; (107(3)):201-204 doi:10.7196/SAMJ.2017.v107i3.11332.

    PMID: 28281424
  8. 8

    Characterization of novel GCDH pathogenic variants causing glutaric aciduria type 1 in the southeast of Mexico.

    Campos-Garcia FJ, Chacon-Camacho OF, Contreras-Capetillo S, et al.

    Molecular genetics and metabolism reports 2019; (21()):100533 doi:10.1016/j.ymgmr.2019.100533.

    PMID: 31788423
  9. 9

    Reversible brain atrophy in glutaric aciduria type 1.

    Numata-Uematsu Y, Sakamoto O, Kakisaka Y, et al.

    Brain & development 2017; (39(6)):532-535 doi:10.1016/j.braindev.2017.01.003.

    PMID: 28143689
  10. 10

    Basal ganglia volume and shape in anorexia nervosa.

    Leppanen J, Cardi V, Sedgewick F, et al.

    Appetite 2020; (144()):104480 doi:10.1016/j.appet.2019.104480.

    PMID: 31586464
  11. 11

    Glutaric Aciduria Type 1 and Acute Renal Failure: Case Report and Suggested Pathomechanisms.

    du Moulin M, Thies B, Blohm M, et al.

    JIMD reports 2018; (39()):25-30 doi:10.1007/8904_2017_44.

    PMID: 28699143
  12. 12

    Investigating the interaction between organic anion transporter 1 and ochratoxin A: An in silico structural study to depict early molecular events of substrate recruitment and the impact of single point mutations.

    Louisse J, Dorne JLCM, Dellafiora L

    Toxicology letters 2022; (355()):19-30 doi:10.1016/j.toxlet.2021.11.001.

    PMID: 34748852
  13. 13

    Deletion of 2-aminoadipic semialdehyde synthase limits metabolite accumulation in cell and mouse models for glutaric aciduria type 1.

    Leandro J, Dodatko T, DeVita RJ, et al.

    Journal of inherited metabolic disease 2020; (43(6)):1154-1164 doi:10.1002/jimd.12276.

    PMID: 32567100
  14. 14

    A knock-in rat model unravels acute and chronic renal toxicity in glutaric aciduria type I.

    Gonzalez Melo M, Fontana AO, Viertl D, et al.

    Molecular genetics and metabolism 2021; (134(4)):287-300 doi:10.1016/j.ymgme.2021.10.003.

    PMID: 34799272
  15. 15

    The lysine degradation pathway: Subcellular compartmentalization and enzyme deficiencies.

    Leandro J, Houten SM

    Molecular genetics and metabolism 2020; (131(1-2)):14-22 doi:10.1016/j.ymgme.2020.07.010.

    PMID: 32768327
  16. 16

    Development of Depotentiation in Adult-Born Dentate Granule Cells.

    Tao X, Sun N, Mu Y

    Frontiers in cell and developmental biology 2019; (7()):236 doi:10.3389/fcell.2019.00236.

    PMID: 31681768
  17. 17

    Acute and Chronic Sleep Deprivation-Related Changes in N-methyl-D-aspartate Receptor-Nitric Oxide Signalling in the Rat Cerebral Cortex with Reference to Aging and Brain Lateralization.

    Kristofikova Z, Sirova J, Klaschka J, Ovsepian SV

    International journal of molecular sciences 2019; (20(13)) doi:10.3390/ijms20133273.

    PMID: 31277281
  18. 18

    N-methyl-d-aspartate receptor function in neuronal and synaptic development and signaling.

    Pagano J, Giona F, Beretta S, et al.

    Current opinion in pharmacology 2021; (56()):93-101 doi:10.1016/j.coph.2020.12.006.

    PMID: 33429227
  19. 19

    Overlapping cortical malformations in patients with pathogenic variants in GRIN1 and GRIN2B.

    Brock S, Laquerriere A, Marguet F, et al.

    Journal of medical genetics 2023; (60(2)):183-192 doi:10.1136/jmedgenet-2021-107971.

    PMID: 35393335
  20. 20

    Patterns, evolution, and severity of striatal injury in insidious- versus acute-onset glutaric aciduria type 1.

    Boy N, Garbade SF, Heringer J, et al.

    Journal of inherited metabolic disease 2018; doi:10.1007/s10545-018-0187-y.

    PMID: 29721918
  21. 21

    Elevated levels of BDNF and cathepsin-d as possible peripheral markers of neurodegeneration in plasma of patients with glutaric acidemia type I.

    Guerreiro G, Diaz Jaques CE, Wajner M, Vargas CR

    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 2020; (80(1)):42-49 doi:10.1002/jdn.10006.

    PMID: 31910296
  22. 22

    Impact of age at onset and newborn screening on outcome in organic acidurias.

    Heringer J, Valayannopoulos V, Lund AM, et al.

    Journal of inherited metabolic disease 2016; (39(3)):341-353 doi:10.1007/s10545-015-9907-8.

    PMID: 26689403
  23. 23

    Impact of newborn screening and quality of therapy on the neurological outcome in glutaric aciduria type 1: a meta-analysis.

    Boy N, Mengler K, Heringer-Seifert J, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2021; (23(1)):13-21 doi:10.1038/s41436-020-00971-4.

    PMID: 32981931

This page explains the GA1 3- to 36-month danger window for educational purposes only. Always follow your metabolic team's emergency protocol and consult your doctor immediately during any illness.

Get notified when new evidence is published on Glutaryl-CoA dehydrogenase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.